Trump announces 0% tariff on generic medicines for two years; 200% thereafter
US President Donald Trump announced a 0% tariff on imported generic medicines for two years, effective August 1, 2026, to promote domestic manufacturing. After this period, a 200% tariff will be imposed to incentivize companies to produce these medicines in the United States. This policy aims to reshape the pharmaceutical landscape by reducing reliance on foreign imports.